Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Fukangbao Koufuye

Approved

中药

Fukangbao Koufuye

东阿阿胶股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 4, 2023
Approval ID: 7LeaeL8IWkr
Company: 东阿阿胶股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeL8IWkr
Approval Number: 国药准字Z20093689
Generic Name: 妇康宝口服液
Generic Name En: Fukangbao Koufuye
Drug Type: 中药
Dosage Form: 合剂
Strength: 每支装10ml
Reg Date: 2023-09-04
Company Name: 东阿阿胶股份有限公司
Company Address: 山东省东阿县阿胶街78号
Production Company Name: 东阿阿胶股份有限公司
Production Company Address: 山东省东阿县阿胶街78号
Company Detail Path: /organization/dong-e-e-jiao-co-ltd
Production Company Detail Path: /organization/dong-e-e-jiao-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 4, 2023

Approval ID

7LeaeL8IWkr

Type

中药

Back to NMPA Approvals

妇康宝口服液 - NMPA Drug Approval Details